These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3731447)

  • 1. Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.
    Sonnenblick M; Eylath U; Brisk R; Eldad C; Hershko C
    Clin Chem; 1986 Aug; 32(8):1537-9. PubMed ID: 3731447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spurious hyperphosphataemia caused by an IgA paraprotein: a topic revisited.
    Sinclair D; Smith H; Woodhead P
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):119-24. PubMed ID: 15025801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spuriously elevated inorganic phosphate level in a multiple myeloma patient.
    Barutçuoglu B; Parildar Z; Mutaf I; Habif S; Bayindir O
    Clin Lab Haematol; 2003 Aug; 25(4):271-4. PubMed ID: 12890170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohyperphosphatemia and dysproteinemia.
    Busse JC; Gelbard MA; Byrnes JJ; Hellman R; Vaamonde CA
    Arch Intern Med; 1987 Nov; 147(11):2045-6. PubMed ID: 3675108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.
    Tian X; Zhao L; Ma J; Lu J; Zhu TY; Liu Y; Sun HX
    Lab Med; 2023 Nov; 54(6):598-602. PubMed ID: 36942666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin.
    Mandry JM; Posner MR; Tucci JR; Eil C
    Cancer; 1991 Sep; 68(5):1092-4. PubMed ID: 1913479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphatemia in multiple myeloma.
    Oren S; Feldman A; Turkot S; Lugassy G
    Ann Hematol; 1994 Jul; 69(1):41-3. PubMed ID: 8061106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohyperphosphataemia in patients with multiple myeloma.
    McClure D; Lai LC; Cornell C
    J Clin Pathol; 1992 Aug; 45(8):731-2. PubMed ID: 1401189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraprotein interference causing pseudohyperphosphataemia: evaluation of an improved methodology.
    Savory DJ; Pearce CJ
    Ann Clin Biochem; 1995 Sep; 32 ( Pt 5)():498-501. PubMed ID: 8830626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of paraprotein interference in determination of plasma inorganic phosphate by ammonium molybdate method.
    Zaman Z; Sneyers L; Van Orshoven A; Blanckaert N; Mariën G
    Clin Chem; 1995 Apr; 41(4):609-14. PubMed ID: 7720254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spurious hyperphosphatemia in multiple myeloma].
    Jarchovsky I; Beitner H; Plavnick L
    Harefuah; 1991 Dec; 121(12):515-6. PubMed ID: 1794758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spuriously high phosphate level which is promptly resolved after plasmapheresis in a patient with multiple myeloma.
    Kiki I; Gundogdu M; Kaya H
    Transfus Apher Sci; 2007 Oct; 37(2):157-9. PubMed ID: 18037346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphate disorders: hyperphosphatemia or pseudohyperphosphatemia?].
    Aeberhard N; Schild C; Rodondi N; Roten-Joss C; Tänzler K
    Praxis (Bern 1994); 2014 Oct; 103(20):1203-6. PubMed ID: 25270750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
    Gore ME; Riches PG; Kohn J
    J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohyperphosphatemia in a patient with multiple myeloma.
    Marcu CB; Hotchkiss M
    Conn Med; 2004 Feb; 68(2):71-2. PubMed ID: 15007869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudohyperphosphataemia incidence in an automatic analyzer.
    Cohen AM; Magazanik A; van-der Lijn E; Shaked P; Levinsky H
    Eur J Clin Chem Clin Biochem; 1994 Jul; 32(7):559-61. PubMed ID: 7981338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isotypic characterization of IgA paraproteins: association with other clinical and analytic data].
    González González JB; García Delgado R; Cámara Sáez E; Ortiz Maslloréns F
    Rev Clin Esp; 1996 Aug; 196(8):529-35. PubMed ID: 8984539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 90-year-old man with hyperphosphatemia.
    Lovekar S; Chen JL
    Am J Kidney Dis; 2011 Feb; 57(2):342-6. PubMed ID: 20951488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical importance of the paraprotein index in multiple myeloma].
    Papajík T; Bacovský J; Zadrazil J; Budíková M; Faltýnek L; Scudla V
    Vnitr Lek; 1994 Aug; 40(8):502-5. PubMed ID: 7941436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement.
    Bowles SA; Tait RC; Jefferson SG; Gilleece MH; Haeney MR
    Ann Clin Biochem; 1994 May; 31 ( Pt 3)():249-54. PubMed ID: 8067665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.